AMG319
目录号: PL09798 纯度: ≥98%
CAS No. :1608125-21-8
商品编号 规格 价格 会员价 是否有货 数量
PL09798-5mg 5mg ¥1050.91 请登录
PL09798-10mg 10mg ¥1730.91 请登录
PL09798-25mg 25mg ¥3585.45 请登录
PL09798-50mg 50mg ¥6181.82 请登录
PL09798-100mg 100mg ¥9520.00 请登录
PL09798-200mg 200mg 询价 询价
PL09798-500mg 500mg 询价 询价
PL09798-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1149.82 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
AMG319
中文别名
(ALPHAS)-7-氟-ALPHA-甲基-N-9H-嘌呤-6-基-2-(2-吡啶基)-3-喹啉甲胺;AMG319 抑制剂;AMG 319
英文名称
AMG319
英文别名
AMG319;AMG-319
Cas No.
1608125-21-8
分子式
C21H16FN7
分子量
385.40
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
AMG319 是一种有效的选择性 PI3Kδ 抑制剂,IC50 为 18 nM。
生物活性
AMG319 is a potent and selective PI3Kδ kinase inhibitor with IC 50 of 18 nM.
性状
Solid
IC50 & Target[1][2]
PI3Kδ 18 nM (IC50) PI3Kγ 850 nM (IC50
体外研究(In Vitro)
AMG319 inhibits PI3Kδ, PI3Kγ, PI3Kβ and PI3Kα with IC50s of 18 nM, 850 nM, 2.7 μM and 33 μM, respectively. AMG319, a compound with an IC50 of 16 nM in a human whole blood assay (HWB), excellent selectivity over a large panel of protein kinases, and a high level of in vivo efficacy as measured by two rodent disease models of inflammation. AMG319 has minimal CYP3A4/2D6 inhibition and does not inhibit CYPs (1A2, 2C8, 2C9, 2C19, 2E1, all >20 μM). There is no time dependent inhibition (TDI) against CYPs 3A4, 2D6, 1A2, and 2C9 nor CYP induction (3A4, 2D6, 1A2, 2B6) as measured in hepatocytes. AMG319 is clean in a hERG binding assay (>25 μM), and an Ames micronucleus test proved negative. AMG319 has minimal effects in a BSEP assay up to >200 μM. Additionally, AMG319 is clean in a large side effect profiling panel (CEREP) and has no activity in a large p
体内研究(In Vivo)
The study is performed to determine the correlation between biochemical coverage (i.e., pAKT) with functional activity in vivo. AMG319 achieves this coverage at the 3 mg/kg level, which also coveres the human whole blood assay (HWB) (CD-69) IC 90 at trough for a full 24 h period. The lower doses 0.1, 0.3, and 1 mg/kg cover trough concentrations between the HWB IC 50 and IC 90 and evince partial efficacy. Similarly, the plasma concentration of AMG319 covers the IC 90 at the 1 mg/kg dose of the mouse anti-IgM pAKT in vitro assay. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Cushing TD, et al. Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease. J Med Chem. 2015 Jan 8;58(1):480-511.
溶解度数据
In Vitro: DMSO : 50 mg/mL (129.74 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2